Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06621407

Active 24 Hours Subperiostal vs. Passive Subdural Drainage After Burr Hole Evacuation of Chronic Subdural Hematoma A Nationwide Randomized Trial

Led by Aalborg University Hospital · Updated on 2025-11-25

354

Participants Needed

4

Research Sites

13 weeks

Total Duration

On this page

Sponsors

A

Aalborg University Hospital

Lead Sponsor

O

Odense University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Chronic subdural hematoma (CSDH) is a common condition often treated by neurosurgical evacuation and drainage of the hematoma. This research aims to compare two drainage methods after surgery: 24 hours of active subperiosteal drainage versus 24 hours of passive subdural drainage. The study is a nationwide, randomized clinical trial conducted across all neurosurgical units in Denmark to evaluate if active drainage is not worse than passive drainage in terms of safety and recurrence. Participants will be adults with symptomatic unilateral CSDH undergoing single burr hole evacuation. Before surgery, patients will be randomly assigned to receive either 24 hours of active subperiosteal drainage or 24 hours of passive subdural drainage. Both drainage methods are already in use, but a direct comparison has not been done. The trial will monitor patients for 90 days post-surgery to assess outcomes. During the study, participants will be evaluated for mortality and recurrence of CSDH requiring reoperation within 90 days. Other assessments include complications related to surgery, length of hospital stay, and functional outcomes measured by the simplified modified Rankin scale. The study uses a double-blind design for patients and statisticians and plans to enroll 354 participants over approximately two years.

CONDITIONS

Brief Title

A National Study Examining the Most Effective Drainage Method After Burr Hole Evacuation of Chronic Subdural Hematoma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients 18 years or older
  • Symptomatic chronic subdural hematoma confirmed by brain CT or MRI
  • Admitted to a Danish neurosurgical department for surgical treatment
  • Undergoing a single burr-hole evacuation
  • Able to give informed written and oral consent prior to surgery
Not Eligible

You will not qualify if you...

  • Mentally incapacitated patients
  • Known abnormalities in cerebrospinal fluid (protein, glucose, cell count, or type)
  • Abnormal cerebrospinal fluid dynamics such as obstructive hydrocephalus, normal pressure hydrocephalus, intracranial hypotension, or ventricular peritoneal shunt
  • Additional or previous intracranial pathology requiring neurosurgical treatment (e.g., brain tumor, vascular malformation, abscess)
  • Recurrent chronic subdural hematoma or previous craniotomy or other transcranial surgery
  • Unable to give consent prior to surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) before surgery

Surgery and Immediate Post-operative Care

Duration - 1 day

Participants undergo a single burr hole evacuation of chronic subdural hematoma followed by placement of either active subperiostal drainage or passive subdural drainage for 24 hours.

1 surgery and immediate post-operative hospital stay

Post-operative Follow-up

Duration - 90 days

Participants are monitored for recovery, complications, and outcomes including recurrence and mortality over 90 days after surgery.

Regular follow-up visits up to 90 days post-surgery

Trial Site Locations

Total: 4 locations

1

Department of Neurosurgery, Aalborg University Hospital

Aalborg, Denmark, 9000

Actively Recruiting

2

Department of Neurosurgery, Aarhus University Hospital

Aarhus, Denmark, 8000

Actively Recruiting

3

Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet

Copenhagen, Denmark, 2100

Actively Recruiting

4

Department of Neurosurgery, Odense University Hospital

Odense, Denmark, 5100

Actively Recruiting

Loading map...

Research Team

C

Carsten R Bjarkam, Professor, Ph.D., DMSc.

R

Rares Miscov, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Prospective, Open-label, Multicenter, Randomized Controlle...

Thyroid Cancer

Actively Recruiting

1 location

Randomized Trial Comparing Adjuvant Tranexamic Acid Versus S...

Chronic Subdural Hematoma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Optimal drainage time after evacuation of chronic subdural haematoma (DRAIN TIME 2): a multicentre, randomised, multiarm and multistage non-inferiority trial in Denmark.

Mads Hjortdal Grønhøj, Thorbjørn Søren Rønn Jensen, Rares Miscov...

https://pubmed.ncbi.nlm.nih.gov/38878790

Active subperiosteal versus passive subdural 24-hour drainage following single burr hole evacuation of chronic subdural haematoma (the SUPERDURA trial): protocol for a multicentre, randomised non-inferiority trial.

Rares Miscov, Mads Grønhøj, Thorbjørn Søren Rønn Jensen...

https://pubmed.ncbi.nlm.nih.gov/41985955

Subperiosteal Drain Insertion and Anchorage after Single Burr Hole Evacuation of Chronic Subdural Hematoma.

Jacob Holmen Terkelsen, Rares Miscov, Mads Hjortdal Grønhøj...

https://pubmed.ncbi.nlm.nih.gov/41628070

Active subperiosteal vs. passive subdural 24-h drainage following single burr hole evacuation of chronic subdural hematoma: statistical analysis plan for the multicenter, randomized, non-inferiority clinical trial SUPERDURA.

Jacob Holmen Terkelsen, Rares Miscov, Thorbjørn Søren Rønn Jensen...

https://pubmed.ncbi.nlm.nih.gov/41546119